�l(f��)���r(sh��)�g��2017/7/12    �l(f��)���ߣ������x���r(n��ng)�I(y��)�Ƽ�����˾
2015����ȫ����݄��Ј�(ch��ng)�N(xi��o)���~238.16�|��Ԫ�����r(n��ng)ˎ���Ј�(ch��ng)�N(xi��o)���~��ռ��41.4%���^2014���½�9.9%���ݸ�좃r(ji��)����^�m(x��)�»������ֳ��݄��Ј�(ch��ng)�IJ������l���Լ��^�͵��r(n��ng)�a(ch��n)Ʒ�r(ji��)��ȹ�ͬӰ���2015����݄����Ј�(ch��ng)�I(y��)��(j��)��
2015���������(l��i)�e�ij��݄��a(ch��n)Ʒ�Ј�(ch��ng)�N(xi��o)���~������ԪӋ(j��)����ͬ���½�������2010��2015���(f��)�������L(zh��ng)�������^ǰ�Ğ�PPO-�����(l��i)���݄���ALS-�����(l��i)���݄���HPPD�(l��i)���݄���
��1 2015��ȫ���N(xi��o)���~ǰ15λ���݄�
��̖(h��o) | ����ͨ���� | Ӣ��ͨ�����Q(ch��ng) | �N(xi��o)���~/ �|��Ԫ | �(l��i)�e | ���� �r(sh��)�g/�� | �_(k��i)�l(f��)��˾ |
1 | �ݸ�� | glyphosate | 49.65 | �������(l��i) | 1972 | ��ɽ�� |
2 | �ٲݿ� | paraquat | 6.95 | (li��n)����(l��i) | 1962 | �����_(d��) |
3 | ���Dz�ͪ | mesotrione | 6.10 | HPPD�(l��i) | 2001 | �����_(d��) |
4 | 2,4-�� | 2,4-D | 6.05 | ���������(l��i) | 1945 | �~�l(f��)��������r(n��ng) |
5 | ���@� | glufosinate | 5.70 | �������(l��i) | 1986 | �ݶ� |
6 | ݬȥ�� | atrazine | 5.65 | ����(l��i) | 1957 | �����_(d��) |
7 | �����ײݰ� | metolachlor | 5.60 | �������(l��i) | 1975 | �����_(d��) |
8 | �Ҳݰ� | acetochlor | 4.30 | �������(l��i) | 1985 | ��ɽ�� |
9 | �������� | pinoxaden | 4.00 | ���� | 2006 | �����_(d��) |
10 | ��Ȳ���ݰ� | flumioxazin | 3.70 | PPO-�����(l��i) | 1993 | ��ɽ�� |
11 | �������` | pendimethalin | 3.50 | �����������(l��i) | 1976 | ��˹�� |
12 | ���f���� | clomazone | 3.10 | ���� | 1986 | ������(sh��) |
13 | ϩ��ͪ | clethodim | 3.00 | �h(hu��n)����ͪ�(l��i) | 1987 | ��ɽ������(��i)��˼�_(d��) |
14 | ��������� | picloram | 2.70 | ����(l��i) | 1963 | �������r(n��ng) |
15 | �ȷ��������� | fluroxypyr | 2.40 | ����(l��i) | 1985 | �������r(n��ng) |
��2 ��ͬ�(l��i)�e���݄��Ј�(ch��ng)�N(xi��o)����r
�(l��i)�e | �(xi��ng)Ŀ | 2010�� | 2014�� | 2015�� | �����L(zh��ng)��/% |
1�� | 5�� |
�������(l��i) | �N(xi��o)���~/�|��Ԫ | 44.50 | 62.85 | 55.39 | -11.9 | +4.5 |
ռ���݄��Ј�(ch��ng)���~/% | 21.8 | 23.8 | 23.3 | �� | �� |
ALS-�������(l��i) | �N(xi��o)���~/�|��Ԫ | 21.59 | 23.09 | 20.19 | -12.6 | -1.3 |
ռ���݄��Ј�(ch��ng)���~/% | 10.6 | 8.7 | 8.5 | �� | �� |
ALS-������ͪ�(l��i) | �N(xi��o)���~/�|��Ԫ | 4.65 | 6.05 | 5.50 | -9.1 | +3.4 |
ռ���݄��Ј�(ch��ng)���~/% | 2.3 | 2.3 | 2.3 | �� | �� |
ALS-�����(l��i) | �N(xi��o)���~/�|��Ԫ | 8.42 | 15.42 | 13.53 | -12.3 | +10.0 |
ռ���݄��Ј�(ch��ng)���~/% | 4.1 | 5.8 | 5.7 | �� | �� |
����(l��i) | �N(xi��o)���~/�|��Ԫ | 9.98 | 12.75 | 11.90 | -6.7 | +3.6 |
ռ���݄��Ј�(ch��ng)���~/% | 4.9 | 4.8 | 5.0 | �� | �� |
�������(l��i) | �N(xi��o)���~/�|��Ԫ | 17.01 | 20.32 | 19.37 | -4.7 | +2.6 |
ռ���݄��Ј�(ch��ng)���~/% | 8.3 | 7.7 | 8.1 | �� | �� |
�����������(l��i) | �N(xi��o)���~/�|��Ԫ | 5.95 | 6.37 | 5.82 | -8.6 | -0.4 |
ռ���݄��Ј�(ch��ng)���~/% | 2.9 | 2.4 | 2.4 | �� | �� |
���������������(l��i) | �N(xi��o)���~/�|��Ԫ | 9.51 | 12.17 | 10.92 | -10.3 | +2.8 |
ռ���݄��Ј�(ch��ng)���~/% | 4.7 | 4.6 | 4.6 | �� | �� |
���(l��i) | �N(xi��o)���~/�|��Ԫ | 3.63 | 4.25 | 4.05 | -4.7 | +2.2 |
ռ���݄��Ј�(ch��ng)���~/% | 1.8 | 1.6 | 1.7 | �� | �� |
�����������(l��i) | �N(xi��o)���~/�|��Ԫ | 3.23 | 4.06 | 3.48 | -14.3 | +1.5 |
ռ���݄��Ј�(ch��ng)���~/% | 1.6 | 1.5 | 1.5 | �� | �� |
(li��n)����(l��i) | �N(xi��o)���~/�|��Ԫ | 7.45 | 10.50 | 8.75 | -16.7 | +3.3 |
ռ���݄��Ј�(ch��ng)���~/% | 3.7 | 4.0 | 3.7 | �� | �� |
����(l��i) | �N(xi��o)���~/�|��Ԫ | 10.04 | 13.28 | 12.45 | -6.3 | +4.4 |
ռ���݄��Ј�(ch��ng)���~/% | 4.9 | 5.0 | 5.2 | �� | �� |
���������(l��i) | �N(xi��o)���~/�|��Ԫ | 7.08 | 9.64 | 8.54 | -11.4 | +3.8 |
ռ���݄��Ј�(ch��ng)���~/% | 3.5 | 3.6 | 3.6 | �� | �� |
PPO-�������(l��i) | �N(xi��o)���~/�|��Ԫ | 3.91 | 5.18 | 4.52 | -12.7 | +2.9 |
ռ���݄��Ј�(ch��ng)���~/% | 1.9 | 2.0 | 1.9 | �� | �� |
PPO-�����(l��i) | �N(xi��o)���~/�|��Ԫ | 4.82 | 11.94 | 11.40 | -4.5 | +18.8 |
ռ���݄��Ј�(ch��ng)���~/% | 2.4 | 4.5 | 4.8 | �� | �� |
�h(hu��n)����ͪ�(l��i) | �N(xi��o)���~/�|��Ԫ | 3.82 | 5.02 | 4.31 | -14.1 | +2.4 |
ռ���݄��Ј�(ch��ng)���~/% | 1.9 | 1.9 | 1.8 | �� | �� |
HPPD�(l��i) | �N(xi��o)���~/�|��Ԫ | 8.64 | 13.92 | 12.87 | -7.5 | +8.3 |
ռ���݄��Ј�(ch��ng)���~/% | 4.2 | 5.3 | 5.4 | �� | �� |
�����(l��i) | �N(xi��o)���~/�|��Ԫ | 19.29 | 27.59 | 25.17 | -8.8 | +5.5 |
ռ���݄��Ј�(ch��ng)���~/% | 9.5 | 10.4 | 10.6 | �� | �� |
��3 ��ͬ�(l��i)�e���݄��Ј�(ch��ng)�A(y��)�y(c��)
�(l��i)�e | 2010��2015�� ��(f��)���� ���L(zh��ng)��/% | 2015�� �N(xi��o)���~/ �|��Ԫ | 2020���A(y��)�y(c��) �N(xi��o)���~(��2015 ��R��Ӌ(j��)��) | 2015��2020�� ��(f��)���� ���L(zh��ng)��/% |
�������(l��i) | +6.3 | 55.39 | 62.50 | +2.4 |
ALS-�������(l��i) | +0.4 | 20.19 | 20.50 | +0.3 |
ALS-������ͪ�(l��i) | +5.2 | 5.50 | 6.50 | +3.4 |
ALS-�����(l��i) | +11.8 | 13.53 | 16.05 | +3.5 |
����(l��i) | +5.4 | 11.90 | 12.75 | +1.4 |
�������(l��i) | +4.4 | 19.37 | 21.40 | +2.0 |
�����������(l��i) | +1.3 | 5.82 | 6.10 | +0.9 |
���������������(l��i) | +4.6 | 10.92 | 11.62 | +1.2 |
���(l��i) | +4.0 | 4.05 | 3.85 | -1.0 |
�����������(l��i) | +3.3 | 3.48 | 3.75 | +1.5 |
(li��n)����(l��i) | +5.0 | 8.75 | 8.50 | -0.6 |
����(l��i) | +6.2 | 12.45 | 14.60 | +3.2 |
���������(l��i) | +5.6 | 8.54 | 11.50 | +6.1 |
PPO-�������(l��i) | +4.7 | 4.52 | 4.75 | +1.0 |
PPO-�����(l��i) | +20.9 | 11.40 | 13.00 | +2.4 |
�h(hu��n)����ͪ�(l��i) | +4.2 | 4.31 | 4.50 | +0.9 |
HPPD�(l��i) | +10.2 | 12.87 | 15.75 | +4.1 |
�����(l��i) | +7.3 | 25.17 | 33.93 | +6.2 |
����(l��i)Դ�����r(n��ng)ˎ��Ӎ�����F(xi��n)���r(n��ng)ˎ�� ����ᣩ